Total Assets Summary of DV Biomed Co., Ltd.

DV Biomed Co., Ltd.'s latest annual total assets in 2023 was 1.81 Billion TWD , down -11.72% from previous year.
DV Biomed Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 617.66 Million TWD , down 0.0% from previous quarter.
DV Biomed Co., Ltd. reported annual total assets of 2.05 Billion TWD in 2022, up 10.2% from previous year.
DV Biomed Co., Ltd. reported annual total assets of 1.86 Billion TWD in 2021, up 1.95% from previous year.
DV Biomed Co., Ltd. reported quarterly total assets of 617.66 Million TWD for 2024 Q1, down -65.92% from previous quarter.
DV Biomed Co., Ltd. reported quarterly total assets of 1.81 Billion TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of DV Biomed Co., Ltd. (2023 - 2019)

Name	Total Assets	Total Assets Difference
Allied Biotech Corporation	2.07 Billion TWD	12.808%
GeneFerm Biotechnology Co., Ltd.	1.17 Billion TWD	-54.219%
Easywell Biomedicals, Inc.	1.21 Billion TWD	-49.338%
TTY Biopharm Company Limited	9.87 Billion TWD	81.644%
Synmosa Biopharma Corporation	11.72 Billion TWD	84.545%
Orient EuroPharma Co., Ltd.	10.81 Billion TWD	83.235%
Center Laboratories, Inc.	27 Billion TWD	93.287%
Tien Liang BioTech Co., Ltd.	654.03 Million TWD	-177.148%
Orient Pharma Co., Ltd.	2.56 Billion TWD	29.267%
InnoPharmax Inc.	524.19 Million TWD	-245.795%
Johnson Chemical Pharmaceutical Works Co., Ltd.	1.99 Billion TWD	9.047%
Excelsior Biopharma Inc.	1.57 Billion TWD	-14.919%
Foresee Pharmaceuticals Co., Ltd.	1.86 Billion TWD	2.622%
Handa Pharmaceuticals, Inc.	3.03 Billion TWD	40.318%
UniPharma Co., Ltd.	350.07 Million TWD	-417.789%
Anxo Pharmaceutical Co., Ltd.	2.21 Billion TWD	18.297%
Alar Pharmaceuticals Inc.	973.2 Million TWD	-86.255%
Winston Medical Supply Co., Ltd.	801.77 Million TWD	-126.079%
Mercury Biopharmaceutical Corporation	438.07 Million TWD	-313.775%
Bioray Biotech Co., Ltd	542.64 Million TWD	-234.037%
TSH Biopharm Corporation Limited	1.39 Billion TWD	-29.488%